Papillomavirus research journal impact factor

Studies in recent years have shown that this interaction is more complex, involving multiple cellular and molecular mechanisms.

External links The aim of the journal is to publish new information that would lead to a better understanding of biological mechanisms of production of human diseases, their prevention and diagnosis as early as possible and to monitor therapy and the development of the health of patients.

The publication is in electronic and printed format.

The frequency is currently four issues per year. Why subscribe RJLabM is a peer-reviewed journal publishing editorials, original scientific and professional articles, general reviews, case reports, guidelines and recommendations of national and international scientific and professional associations, book reviews and announces events congresses, symposia, courses in the field of Laboratory Medicine.

Its aim is to publish new information that can lead to a better understanding of the biological mechanisms of human diseases, improve prophylaxis and early diagnosis, as well as therapy papillomavirus research journal impact factor and patient health status.

The Editorial Board and Scientific Reviewers are outstanding scientists ensuring high quality information within the journal. The peer-review system provided by experts is fair and constructive.

Can women of any age have the human papillomavirus (HPV) vaccine?

Rejection Rate Average time to final decision days CrossCheck Plagiarism Screening System The editorial board is participating in a growing community of CrossCheck System's users in order to ensure that the content published is original and trustworthy. CrossCheck is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process.

Detailed description of the CrossCheck System can be found at:.